aTyr Pharma, Inc.ATYRNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank62
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P62
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-14.30%
2024-23.66%
2023-18.35%
2022-36.42%
2021-113.78%
202030.76%
201929.99%
201830.38%
201720.55%
2016-24.62%